Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Moody's
MCO
5
Jefferies Financial
JEF
CA Stock MarketDetailed Quotes
JNJ Johnson & Johnson CDR (CAD Hedged)
- 20.470
- +0.120+0.59%
15min DelayTrading May 2 10:24 ET
506.62BMarket Cap16.27P/E (TTM)
20.600High20.470Low1.33KVolume20.600Open20.350Pre Close27.20KTurnover22.44052wk High0.00%Turnover Ratio24.75BShares18.60252wk Low1.258EPS TTM506.44BFloat Cap22.440Historical High25.27P/E (Static)24.74BShs Float18.602Historical Low0.81EPS LYR0.64%Amplitude0.69Dividend TTM4.70P/B1Lot Size3.35%Div YieldTTM
About Johnson & Johnson CDR (CAD Hedged) Company
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. Geographically, just over half of total revenue is generated in the United States.
Company Profile
SymbolJNJ
Company NameJohnson & Johnson CDR (CAD Hedged)
Founded1887
MarketNEOE
Employees138100
Fiscal Year Ends12-31
AddressOne Johnson & Johnson Plaza
CityNew Brunswick
CountryUnited States of America
Zip Code08933
Phone+1 732 524-0400
Websitehttps://www.jnj.com
Company Executives
- Name
- Position
- Salary
- Joaquin Duato
- Chairman of the Board and Chief Executive Officer
- 24.30M
- Kristen Mulholland
- Executive Vice President and Chief Human Resources Officer
- --
- Kathryn E. Wengel
- Executive Vice President and Chief Technical Operations & Risk Officer
- --
- Elizabeth Forminard
- Executive Vice President and Chief Legal Officer
- --
- Robert J. Decker, Jr
- Controller and Chief Accounting Officer
- --
- Joseph J. Wolk, C.P.A.
- Executive Vice President and Chief Financial Officer
- 12.62M
- James D. Swanson
- Executive Vice President and Chief Information Officer
- --
- Vanessa Broadhurst
- Executive Vice President, Global Corporate Affairs
- --
- Jennifer L. Taubert
- Executive Vice President and Worldwide Chairman, Innovative Medicine
- 11.19M
- Timothy Schmid
- Executive Vice President and Worldwide Chairman, MedTech
- 11.86M
- Dr. John C. Reed,M.D.,PhD
- Executive Vice President, Innovative Medicine, R&D
- 9.30M
- Marillyn A. Hewson
- Lead Independent Director
- 409.29K
- Anne M. Mulcahy
- Independent Director
- 390.71K
- Mark A. Weinberger
- Independent Director
- 355.00K
- Hubert Joly
- Independent Director
- 370.00K
- Eugene A. Woods
- Independent Director
- 330.00K
- Dr. Paula A. Johnson,M.D.
- Independent Director
- 360.00K
- Dr. Nadja Y. West, M.D.
- Independent Director
- 350.00K
- Dr. Mary C. Beckerle, PhD
- Independent Director
- 380.00K
- Dr. Mark B. McClellan, M.D.,PhD
- Independent Director
- 334.00K
- Dr. Jennifer A. Doudna, PhD
- Independent Director
- 350.00K
- Darius E. Adamczyk
- Independent Director
- 359.18K
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. Do you think Buffett was scooping up stocks during the recent dip? 2. In the face of market changes, do you prefer to stick
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts